← Back to Patent Explorer
US4594425A Expired / Lapsed US ⏱️ 0.0 years remaining

Heterocyclic compounds as antiallergic agents

Assignee: Wyeth LLC
•
Filing: 1984-02-09
•
Granted: 1986-06-10
•
Expires: 2004-02-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are disclosed compounds of the formula <IMAGE> wherein <IMAGE> <IMAGE> <IMAGE> +TR <IMAGE> <IMAGE> n is 0-6; A is O or S; B is OR2, SR2 or N(R2)2; R1 is hydrogen, loweralkyl, loweralkoxy or halo; R2 is hydrogen or loweralkyl; and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstructive airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like.

Inventors

  • 👤 John H. Musser
  • 👤 Dennis M. Kubrak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 08:50
CPC Classifications
C; C07; C07D; C07D277/00; C07D277/60; C07D277/62; C07D277/68; C07D277/64; C07D307/00; C07D307/77; C07D307/78; C07D307/79; C07D307/80

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 47 words
A compound having the formula ##STR11## n is 0-6; A is O or S; B is OR 2 , SR 2 or N(R 2 ) 2 ; R 1 is hydrogen, loweralkyl, loweralkoxy or halo; R 2 is hydrogen or loweralkyl; and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 47 words
A compound having the formula ##STR11## n is 0-6; A is O or S; B is OR 2 , SR 2 or N(R 2 ) 2 ; R 1 is hydrogen, loweralkyl, loweralkoxy or halo; R 2 is hydrogen or loweralkyl; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 11 words
The compound of claim 1, which is 4-[[3-[(2-benzthiazolyl)methoxy]phenyl]amino]-4-oxobutanoic acid, methyl ester.
Claim 4
Dependent Claim 11 words
The compound of claim 1, which is 4-[[3-[(2-benzoxazolyl)methoxy]phenyl]amino]-4-oxobutanoic acid, methyl ester.
Claim 5
Dependent Claim 11 words
The compound of claim 1 which is 4-[[3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl]amino-4-oxobutanoic acid, methyl ester.
Claim 6
Dependent Claim 11 words
The compound of claim 1, which is 3-[[3-[(2-benzthiazolyl)methoxy]phenyl]amino]-3-oxopropanoic acid, methyl ester.
Claim 7
Dependent Claim 11 words
The compound of claim 1, which is 3-[[3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl]amino]-3-oxopropanoic acid, methyl ester.
Claim 8
Dependent Claim 11 words
The compound of claim 1, which is 4-[[3-[(2-benzthiazolyl)oxy]phenyl]amino]-4-oxobutanoic acid, methyl ester.
Claim 9
Dependent Claim 11 words
The compound of claim 1, which is 4-[N-methyl-[3-[(2-benzthiazolyl)methoxy]phenyl]amino]-4-oxobutanoic acid, methyl ester.
Claim 10
Dependent Claim 11 words
The compound of claim 1, which is 4-[[3-[(2-benzthiazolyl)methoxy]phenyl]hydroxylamino]-4-oxobutanoic acid, methyl ester.

References Cited (Backward Citations)

GB1000405A Cited
US3594373A Cited
US3740413A Cited
US4130413A Cited
US4314065A Cited
US4296129A Cited
US4448965A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-09 1989-12-09 1990-06-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-09 1993-12-09 1994-06-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-09 1997-12-09 1998-06-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag